US · Real Estate · REIT - Healthcare Facilities
EPS came in at 0.40 against a street estimate of 0.38 — a beat of 5.3%.
Analysts rate Sabra Healthcare REIT Inc a buy (6 buy, 10 hold, 0 sell out of 16) with an average price target of $22.79.
CONFIDENT SBRA closed $600M investments Q2, grew SHOP NOI 13.7% YoY, raised 2026 FFO/AFFO guidance to 7%/8% growth. Leverage fell to 4.61x. Pipeline exceeds $1.3B, nearly all SHOP. Q2 2026 Canadian portfolio 9 consecutive quarters >90% occupancy. Cap rates 100–150bps inside US. RevPOR growth continues despite high occupancy. Analysts pressed on SHOP growth sustainability vs peers, SNF scarcity vs SHOP volume, and value-add occupancy risk. Management emphasized 80% value-add is low-risk with proven operators, SNF supply structural, and SHOP momentum durable given industry tailwinds. 2026-08-04…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 16.29% |
| Principal Financial Group Inc | 9.67% |
| Vanguard Portfolio Management, LLC | 9.14% |
| State Street Corp | 4.82% |
| Vanguard Capital Management, LLC | 4.44% |
| Geode Capital Management, LLC | 3.10% |
| CenterSquare Investment Management LLC | 2.28% |
| Bank of America Corp | 2.08% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 SABRA HEALTH CARE REIT, INC. - Q2 2026 SUMMARY HEADLINE NUMBERS • Total Assets: $5,512.6 million as of June 30, 2026 (up from $5,493.4 million at De | 2026-08-03 |
| Results announced · Q3 2026 SABRA HEALTH CARE REIT Q2 2026 SUMMARY HEADLINE NUMBERS • Net Income (Loss): Q2 2026 loss of $25.2 million vs. Q2 2025 profit of $65.5 million; six- | 2026-08-03 |
| Reg FD disclosure · Q3 2026 SABRA HEALTH CARE REIT, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Document Type: Form 8-K Current Report filed July 21, 2026 • Company: Sabra Healt | 2026-07-21 |
| Shareholder vote results · Q2 2026 SABRA HEALTH CARE REIT, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting Date: June 17, 2026 • Total Votes Cast (Director Election): Approx | 2026-06-17 |
| Reg FD disclosure · Q2 2026 SABRA HEALTH CARE REIT, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Document Type: Form 8-K Current Report filed May 28, 2026 • Company: Sabra Health | 2026-05-28 |
| Quarterly report · Q1 2026 SABRA HEALTH CARE REIT, INC. — Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total Assets: $5,591,190 thousand as of March 31, 2026 (up from $5,493,3 | 2026-04-29 |
| Proxy statement · Q2 2026 SABRA HEALTH CARE REIT, INC. — 2026 PROXY SUMMARY --- CEO TOTAL COMPENSATION & CHANGES • Richard K. Matros (CEO) — Total 2025 compensation: $3,693, | 2026-04-24 |
| Annual report FY2025 SABRA HEALTH CARE REIT, INC. — 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market capitalization: $4.4 billion (as of June 30, 2025, most r | 2026-02-12 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.30 / share ex-date Aug 14, 2026 · pay Aug 31, 2026 | 2026-08-14 |
| Dividend | $0.30 / share ex-date May 15, 2026 · pay May 29, 2026 | 2026-05-15 |
| Dividend | $0.30 / share ex-date Feb 13, 2026 · pay Feb 27, 2026 | 2026-02-13 |
| Dividend | $0.30 / share ex-date Nov 17, 2025 · pay Nov 28, 2025 | 2025-11-17 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sabra Healthcare REIT Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.